Rezultati - Adeline Ayrolles-Torro
- Showing 1 - 2 results of 2
-
1
Antibody targeting of claudin-1 as a potential colorectal cancer therapy od Sara Cherradi, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, N. Gueguinou, Vincent Denis, Eve Combès, Florence Boissière‐Michot, Muriel Busson, Lucile Canterel-Thouennon, Caroline Mollévi, Martine Pugnière, Frédéric Bibeau, Marc Ychou, Pierre Martineau, Céline Gongora, Maguy Del Rio
Izdano 2017Artigo -
2
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer od Laetitia Marzi, Eve Combès, Nadia Vié, Adeline Ayrolles-Torro, Diégo Tosi, Delphine Désigaud, Esther Pérez-Gracia, Christel Larbouret, Clara Montagut, Mar Iglesias, Marta Jarlier, Vincent Denis, Laëtitia K. Linares, Eric W.‐F. Lam, Pierre Martineau, Maguy Del Rio, Céline Gongora
Izdano 2016Artigo
Iskalna orodja:
Sorodne teme
Apoptosis
Biochemistry
Biology
Cancer
Cancer research
Cell biology
Colorectal cancer
Internal medicine
Medicine
Antibody
Cell growth
Cetuximab
Claudin
Clonogenic assay
Downregulation and upregulation
Epidermal growth factor receptor
Flow cytometry
Gene
Genetics
Immunology
KRAS
MAPK/ERK pathway
Molecular biology
Monoclonal antibody
Oncology
Signal transduction
Tight junction